FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisabeth Diez

Research Profile

Disorders

Melanoma

Anatomy

Chemicals & Drugs

Physiology

Concepts & Ideas

T-Lymphocyte Subsets

Co-author Network

Publications

TOP 3
Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Céline Aznar; Philippe Picard; Serge Geoffre; Aline Huet; Marie-Lise Bourguet-Kondracki; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.
Murielle Corvaisier; Agnès Moreau-Aubry; Elisabeth Diez; Jaafar Bennouna; Jean-Francois Mosnier; Emmanuel Scotet; Marc Bonneville; Francine Jotereau
V gamma 9V delta 2 T cell response to colon carcinoma cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisabeth Diez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Journal of medicinal chemistry 2007;50(7):1598-609.
2006: Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Céline Aznar; Philippe Picard; Serge Geoffre; Aline Huet; Marie-Lise Bourguet-Kondracki; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.
Molecular bioSystems 2006;2(5):240-9.
2005: Murielle Corvaisier; Agnès Moreau-Aubry; Elisabeth Diez; Jaafar Bennouna; Jean-Francois Mosnier; Emmanuel Scotet; Marc Bonneville; Francine Jotereau
V gamma 9V delta 2 T cell response to colon carcinoma cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(8):5481-8.
2005: Emmanuelle Godefroy; Agnès Moreau-Aubry; Elisabeth Diez; Brigitte Dreno; Francine Jotereau; Yannick Guilloux
alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.
The Journal of experimental medicine 2005;202(1):61-72.
2003: Houssem Benlalam; Boris Linard; Yannick Guilloux; Agnès Moreau-Aubry; Laurent Derré; Elisabeth Diez; Brigitte Dreno; Francine Jotereau; Nathalie Labarrière
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(11):6283-9.
2002: Nathalie Labarrière; Laurent Bretaudeau; Nadine Gervois; Marie Bodinier; Gwenola Bougras; Elisabeth Diez; François Lang; Marc Gregoire; Francine Jotereau
Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen.
International journal of cancer. Journal international du cancer 2002;101(3):280-6.
2002: Laurent Derré; Murielle Corvaisier; Marie-Christine Pandolfino; Elisabeth Diez; Francine Jotereau; Nadine Gervois
Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(10):4864-70.
2002: Boris Linard; Stéphane Bézieau; Houssem Benlalam; Nathalie Labarrière; Yannick Guilloux; Elisabeth Diez; Francine Jotereau
A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4802-8.
2001: Houssem Benlalam; Nathalie Labarrière; Boris Linard; Laurent Derré; Elisabeth Diez; Marie-Christine Pandolfino; Marc Bonneville; Francine Jotereau
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.
European journal of immunology 2001;31(7):2007-15.
2000: Nadine Gervois; Nathalie Labarriere; S Le Guiner; Marie-Christine Pandolfino; Jean-François Fonteneau; Yannick Guilloux; Elisabeth Diez; Brigitte Dreno; Francine Jotereau
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1459-67.
1999: C Ibisch; Géraldine Gallot; Régine Vivien; Elisabeth Diez; Francine Jotereau; R Garand; Henri Vié
Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Bone marrow transplantation 1999;23(11):1153-9.
1998: Nathalie Labarriere; Marie-Christine Pandolfino; D Raingeard; S Le Guiner; Elisabeth Diez; E Le Dréan; Brigitte Dreno; Francine Jotereau
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
International journal of cancer. Journal international du cancer 1998;78(2):209-15.
1998: S Le Guiner; E Le Dréan; Nathalie Labarrière; Jean-François Fonteneau; C Viret; Elisabeth Diez; Francine Jotereau
LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal.
European journal of immunology 1998;28(4):1322-31.
1997: Jean-François Fonteneau; E Le Dréan; S Le Guiner; Nadine Gervois; Elisabeth Diez; Francine Jotereau
Heterogeneity of biologic responses of melanoma-specific CTL.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2831-9.
1997: L Toujas; J G Delcros; Elisabeth Diez; Nadine Gervois; G Semana; G Corradin; Francine Jotereau
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.
Immunology 1997;91(4):635-42.
1997: Nathalie Labarriere; Elisabeth Diez; Marie-Christine Pandolfino; C Viret; Yannick Guilloux; S Le Guiner; Jean-François Fonteneau; Brigitte Dreno; Francine Jotereau
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1238-45.
1996: Nadine Gervois; Y Guilloux; Elisabeth Diez; Francine Jotereau
Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions.
The Journal of experimental medicine 1996;183(5):2403-7.
1995: C Viret; Nadine Gervois; Y Guilloux; E Le Dréan; Elisabeth Diez; Francine Jotereau
T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
International immunology 1995;7(10):1535-43.
1995: E Le Dréan; Nadine Gervois; Elisabeth Diez; G Semana; Brigitte Dreno; Francine Jotereau
HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes.
European journal of immunology 1995;25(10):2732-6.
1994: Y Guilloux; C Viret; Nadine Gervois; E Le Dréan; Marie-Christine Pandolfino; Elisabeth Diez; Francine Jotereau
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
European journal of immunology 1994;24(9):1966-73.
1992: F Heuze; Drew M Pardoll; Elisabeth Diez; S Ezine; Francine Jotereau
Molecular analysis of a pro-T cell clone transformed by Abelson-murine leukemia virus, displaying progressive gamma delta T cell receptor gene rearrangement and surface expression.
European journal of immunology 1992;22(8):2077-84.
1992: Marie-Christine Pandolfino; C Viret; Nadine Gervois; Y Guilloux; François Davodeau; Elisabeth Diez; Francine Jotereau
Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
European journal of immunology 1992;22(7):1795-802.
1991: Francine Jotereau; Marie-Christine Pandolfino; D Boudart; Elisabeth Diez; Brigitte Dreno; J Y Douillard; J Y Muller; B LeMevel
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(6):405-11.
1990: Nadine Gervois; F Heuze; Elisabeth Diez; Francine Jotereau
High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.
Human immunology 1990;28(2):112-8.
1990: Nadine Gervois; F Heuze; Elisabeth Diez; Francine Jotereau
Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
European journal of immunology 1990;20(4):825-31.
1987: D Aubert; F Heuze; Elisabeth Diez; Francine Jotereau; R Berger
Cytogenetics of Abelson virus-induced malignant lymphoma cell lines in the mouse.
Cancer genetics and cytogenetics 1987;28(1):119-25.